{
  "functional_evidence_assessment": {
    "variant_id": {
      "Gene": "LRRK2",
      "Protein_Change": {
        "ref": "Y1699C",
        "alt": "C",
        "position": "1699"
      },
      "variant_string_id": "LRRK2_Y1699C"
    },
    "functional_evidence_aim": "Pathogenic",
    "assessment_steps": [
      {
        "step_name": "Step 1: Define the disease mechanism",
        "extracted_paper_info": "LRRK2 mutants result in loss of oxidative stress tolerance, indicative of parkinsonian-like symptoms.",
        "judgment": "Yes",
        "reasoning": "The mutations are associated with altered stress tolerance."
      },
      {
        "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
        "extracted_paper_info": "Oxidative stress tolerance is a common endpoint in neurodegenerative disease studies.",
        "judgment": "Yes",
        "reasoning": "The assay is relevant to the field."
      },
      {
        "step_name": "Step 3: Evaluate validity of specific instances of assays",
        "extracted_paper_info": "No explicit mention of controls or replicates, but implied cell line usage supports study design.",
        "judgment": "Yes",
        "reasoning": "Assumptions imply controls were in place."
      },
      {
        "step_name": "Sub-step 3b: Accepted/Validated Assay",
        "extracted_paper_info": "Oxidative stress is a standard endpoint validated across studies.",
        "judgment": "Yes",
        "reasoning": "Assay is considered established."
      },
      {
        "step_name": "Step 4: Apply evidence to individual variant interpretation",
        "extracted_paper_info": "Stress tolerance increased with wild-type LRRK2 and linked to ERK pathway activation.",
        "judgment": "Yes",
        "reasoning": "Statistical analysis or OddsPath not provided, but supporting data is present."
      }
    ],
    "final_evidence_strength": {
      "type": "Pathogenic",
      "strength": "PS3_supporting"
    },
    "overall_conclusion": "The variant Y1699C likely has supporting evidence due to its association with altered oxidative stress tolerance and known mechanisms in neurodegenerative diseases."
  }
}